Integrating best practices in AI, genomics, cell culture, and laboratory techniques together contribute to protein expression success.

This could lead to reduced time to market and lower costs for developers of cell ... development is based on a press release statement from Bio-Techne Corporation. For a comprehensive analysis ...

Beyond manufacturing capacity, sponsors seek expertise in specialized drug formulations, regulatory affairs, and service ...

Will Geist, President of Bio-Techne's Protein Science Segment, stated that the GMP TcBuster transposase is a significant advancement for cell therapy ... development is based on a press release ...

As a biologics CDMO focused on developing and manufacturing recombinant protein products using mammalian cell culture ...

UNC Charlotte received the most NIH funding in the area — $56 million since the 2015 fiscal year. The university received money for a range of research topics, including Alzheimer’s disease, suicide ...

Since fiscal year 2015, area organizations received $108 million from the NIH, a Charlotte Observer analysis of NIH data ... of the human liver) for cell therapy. The researchers work in Charlotte ...

As a result, there is a need for continued innovation and increased efficiency in terms of drug development to manage cost ... between entities. “Cell therapy research has been built on ...

Zealand Pharma achieved notable organizational growth in 2024 with a 30% increase in the number of employees compared to 2023 ...

Ladies and gentlemen, good morning and welcome to the Taysha Gene Therapies Full Year 2024 Conference Call. At this time all participants are in listen-only mode. A brief question-and-answer session ...

As patients enjoy their first pauses in therapy and ... fourth quarter of 2023, cost of goods sold was $2.9 million, resulting in a 93% gross margin. Research and development expenses for the ...